SF Prep Notes

National Biodiversity Authority disburses ₹5.68 crore in benefit-sharing funds

On 30 August 2026, the National Biodiversity Authority said it had disbursed ₹5.68 crore under the Access and Benefit-Sharing mechanism, mainly linked to okra, cucumber and watermelon resources.

Summary

The National Biodiversity Authority (NBA) said on 30 August 2026 that it had disbursed ₹5.68 crore under the Access and Benefit-Sharing (ABS) mechanism arising from the use of biological resources. The funds went to State Biodiversity Boards, Union Territory Biodiversity Councils and a national research institution, mainly for okra, cucumber and watermelon. The largest component, ₹3.51 crore, relates to okra (139 varieties and 28 hybrids) and was released to 32 State Boards and UT Councils; that amount came from Nunhems India Pvt. Ltd. Other components involved watermelon and cucumber accessed by Nunhems India, East West Seeds India and Bayer Science and Innovation.

Key facts

Body
National Biodiversity Authority (NBA)
Amount
₹5.68 crore under ABS
Largest share
Okra – ₹3.51 crore to 32 SBBs/UTBCs
Resources
Okra, cucumber, watermelon; microbial and agricultural resources
Companies
Nunhems India, East West Seeds India, Bayer Science and Innovation

Practice MCQs 2 questions

Q1 Advanced

The largest component of the ₹5.68 crore Access and Benefit-Sharing funds disbursed by the NBA in August 2026 related to which crop?

Show answer

Correct answer: A — Okra

Okra (139 varieties, 28 hybrids) accounted for ₹3.51 crore released to 32 SBBs/UTBCs.

Q2 Advanced

Consider the following statements about the NBA's August 2026 ABS disbursement: 1. The ABS amount for okra was received from Bayer Science and Innovation Pvt. Ltd. 2. The funds were channelled to State Biodiversity Boards, UT Biodiversity Councils and a national research institution. Which of the above is/are correct?

Show answer

Correct answer: B — 2 only

Statement 1 is wrong: the okra ABS amount came from Nunhems India Pvt. Ltd. Statement 2 is correct.

← All current affairs